Riskpilot← Back to searchSign inGet full accessMEDIQ NORGES STIFTELSE
STIActiveOrg 976657152Brynsveien 14, 0667 OsloActivities of other membership organisations n.e.c. · NACE 9499Est. 19780 employees
Revenue 2025
NOK 0
EBITDA margin
—
-10% vs 2024
Equity ratio
98.8%
Financial strength
Net profit 2025
NOK -54K
-11% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -54K | -10% |
| Net profit | NOK -54K | -11% |
| Total assets | NOK 833K | -6% |
| Equity | NOK 823K | -6% |
| Employees | 0 | — |
Legal name
MEDIQ NORGES STIFTELSE
Org number
976657152
Legal form
Stiftelse
NACE code
9499 · Activities of other membership organisations n.e.c.
Founded
11. desember 1978
Share capital
—
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Address
Brynsveien 14, 0667 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 67 | 39 | 32 | 34 | 35 | 32 | 12 | 2 | 6 | 5 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | −20 | −32 | −17 | −9 | −17 | −15 | −24 | −34 | −27 | −28 | −17 | −23 | −28 | −67 | −53 | −49 | −49 | −54 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −20 | −32 | −17 | −9 | −17 | −15 | −24 | −34 | −27 | −28 | −17 | −23 | −28 | −67 | −53 | −49 | −49 | −54 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 5 | 4 | 4 | 232 | 1 | 0 |
| Profit before tax | 0 | −20 | −32 | −17 | −9 | −17 | −15 | −24 | −34 | −27 | −28 | −17 | −18 | −23 | −63 | −50 | 182 | −49 | −54 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −20 | −32 | −17 | −9 | −17 | −15 | −24 | −34 | −27 | −28 | −17 | −18 | −23 | −63 | −50 | 182 | −49 | −54 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 1 137 | 1 144 | 1 084 | 1 069 | 1 057 | 1 027 | 1 003 | 968 | 941 | 913 | 896 | 888 | 875 | 792 | 763 | 935 | 887 | 833 |
| Equity | — | 1 117 | 1 085 | 1 068 | 1 059 | 1 042 | 1 027 | 1 003 | 968 | 941 | 913 | 896 | 878 | 855 | 792 | 743 | 925 | 877 | 823 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 20 | 59 | 16 | 10 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 20 | 0 | 20 | 10 | 10 | 10 |
| Total debt | 0 | 20 | 59 | 16 | 10 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 20 | 0 | 20 | 10 | 10 | 10 |
EBITDA margin
-5429000.0%
This company
15.8%
Market median
-34360859% vs market
20072025
Equity ratio
98.8%
This company
38.2%
Market median
+159% vs market
20072025
Return on equity
-6.6%
This company
18.4%
Market median
-136% vs market
20072025
Net profit margin
-5395700.0%
This company
8.1%
Market median
-66613680% vs market
20072025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20072025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20072025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-02 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDIQ NORGES STIFTELSE also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ellen Engh Pellerud | Board of Directors | 0 companies |
| Ingrid Paaske Gulbrandsen | Board of Directors | 0 companies |
| Rune Veum | Board of Directors | 0 companies |
| Hege Ross Balnagown Christiansen | Chairman | 0 companies |
| Kari Hoff-Okstad | Board of Directors | 0 companies |
| Anders Vollen | Board of Directors | 0 companies |